192 related articles for article (PubMed ID: 36741845)
1. Sex and age differences in sST2 in cardiovascular disease.
Beetler DJ; Bruno KA; Di Florio DN; Douglass EJ; Shrestha S; Tschöpe C; Cunningham MW; Krejčí J; Bienertová-Vašků J; Pankuweit S; McNamara DM; Jeon ES; van Linthout S; Blauwet LA; Cooper LT; Fairweather D
Front Cardiovasc Med; 2022; 9():1073814. PubMed ID: 36741845
[TBL] [Abstract][Full Text] [Related]
2. Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis.
Coronado MJ; Bruno KA; Blauwet LA; Tschöpe C; Cunningham MW; Pankuweit S; van Linthout S; Jeon ES; McNamara DM; Krejčí J; Bienertová-Vašků J; Douglass EJ; Abston ED; Bucek A; Frisancho JA; Greenaway MS; Hill AR; Schultheiss HP; Cooper LT; Fairweather D
J Am Heart Assoc; 2019 Jan; 8(2):e008968. PubMed ID: 30638108
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
[TBL] [Abstract][Full Text] [Related]
4. Soluble ST2 and myocardial fibrosis in 3T cardiac magnetic resonance.
Quick S; Waessnig NK; Kandler N; Poitz DM; Schoen S; Ibrahim K; Strasser RH; Speiser U
Scand Cardiovasc J; 2015; 49(6):361-6. PubMed ID: 26287645
[TBL] [Abstract][Full Text] [Related]
5. Sex and gender differences in myocarditis and dilated cardiomyopathy: An update.
Fairweather D; Beetler DJ; Musigk N; Heidecker B; Lyle MA; Cooper LT; Bruno KA
Front Cardiovasc Med; 2023; 10():1129348. PubMed ID: 36937911
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders.
Grakova EV; Kopeva KV; Teplyakov AT; Ogurkova ON; Garganeeva AA; Garmaeva OV
Ter Arkh; 2019 Mar; 91(1):32-37. PubMed ID: 31090368
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis.
Zhang T; Xu C; Zhao R; Cao Z
Front Cardiovasc Med; 2021; 8():697837. PubMed ID: 34368254
[TBL] [Abstract][Full Text] [Related]
8. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
[TBL] [Abstract][Full Text] [Related]
9. Soluble ST2 protein in chronic heart failure is independent of traditional factors.
Wojtczak-Soska K; Pietrucha T; Sakowicz A; Lelonek M
Arch Med Sci; 2013 Feb; 9(1):21-6. PubMed ID: 23515651
[TBL] [Abstract][Full Text] [Related]
10. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
[TBL] [Abstract][Full Text] [Related]
11. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis.
Wang J; He M; Li H; Chen Y; Nie X; Cai Y; Xie R; Li L; Chen P; Sun Y; Li C; Yu T; Zuo H; Cui G; Miao K; Zhao C; Jiang J; Heidecker B; Barnett O; Maisel A; Chen C; Wang DW
J Am Heart Assoc; 2022 Apr; 11(7):e024417. PubMed ID: 35377184
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
[TBL] [Abstract][Full Text] [Related]
14. Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females.
Dieplinger B; Egger M; Poelz W; Gabriel C; Haltmayer M; Mueller T
Clin Chem Lab Med; 2011 Sep; 49(9):1515-8. PubMed ID: 21663467
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
16. Soluble ST2 proteins in male cachectic patients with chronic heart failure.
Sobieszek G; Powrózek T; Jaroszyński A; Skwarek-Dziekanowska A; Rahnama-Hezavah M; Małecka-Massalska T
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):886-893. PubMed ID: 33549461
[TBL] [Abstract][Full Text] [Related]
17. Soluble ST2, Galectin-3 and clinical prognosis of patients with hypertrophic cardiomyopathy undergoing ventricular septal myectomy: a correlation analysis.
Song B; Yao B; Dang H; Dong R
Cardiovasc Diagn Ther; 2020 Apr; 10(2):145-152. PubMed ID: 32420094
[TBL] [Abstract][Full Text] [Related]
18. Temporal changes of soluble ST2 after cardiovascular interventions.
Willems S; Sels JW; Flier S; Versteeg D; Buhre WF; de Kleijn DP; Hoefer IE; Pasterkamp G
Eur J Clin Invest; 2013 Feb; 43(2):113-20. PubMed ID: 23215810
[TBL] [Abstract][Full Text] [Related]
19. Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.
Coglianese EE; Larson MG; Vasan RS; Ho JE; Ghorbani A; McCabe EL; Cheng S; Fradley MG; Kretschman D; Gao W; O'Connor G; Wang TJ; Januzzi JL
Clin Chem; 2012 Dec; 58(12):1673-81. PubMed ID: 23065477
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
